PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.34 - 0.34
0.23 - 0.41
110.0K / 51.2K (Avg.)
-1.33 | -0.26
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
169.78%
Revenue growth above 1.5x 8198.HK's 107.02%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
155.92%
Gross profit growth above 1.5x 8198.HK's 37.53%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
No Data
No Data available this quarter, please select a different quarter.
-11.38%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-22.27%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-25.00%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-25.00%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
0.00%
Slight or no buybacks while 8198.HK is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-150.29%
Negative OCF growth while 8198.HK is at 0.00%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-151.12%
Negative FCF growth while 8198.HK is at 0.00%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
-95.07%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-84.27%
Negative 5Y CAGR while 8198.HK stands at 1089.64%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-52.13%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
-134.80%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-106.88%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-133.72%
Negative 3Y OCF/share CAGR while 8198.HK stands at 57.72%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
-286.02%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
-554.45%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-22938.97%
Negative 3Y CAGR while 8198.HK is 15.14%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
-40.61%
Negative equity/share CAGR over 10 years while 8198.HK stands at 113.63%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-41.53%
Both show negative equity/share growth mid-term. Martin Whitman suspects cyclical or structural challenges for each company.
-42.11%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Firm’s AR is declining while 8198.HK shows 0.00%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-100.00%
Inventory is declining while 8198.HK stands at 0.00%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-13.28%
Negative asset growth while 8198.HK invests at 0.00%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-12.51%
We have a declining book value while 8198.HK shows 0.00%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
34.59%
Debt growth of 34.59% while 8198.HK is zero. Bruce Berkowitz sees additional leverage that must yield profitable expansions to be worthwhile.
117.33%
R&D growth of 117.33% while 8198.HK is zero. Bruce Berkowitz checks if the moderate investment leads to meaningful product differentiation.
13.96%
SG&A declining or stable vs. 8198.HK's 284.46%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.